{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T17:25:39Z","timestamp":1694625939486},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2006,1,30]],"date-time":"2006-01-30T00:00:00Z","timestamp":1138579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,1,30]],"date-time":"2006-01-30T00:00:00Z","timestamp":1138579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2006,3,1]]},"DOI":"10.1038\/sj.bmt.1705275","type":"journal-article","created":{"date-parts":[[2006,2,2]],"date-time":"2006-02-02T11:27:40Z","timestamp":1138879660000},"page":"615-615","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Will a reduced-toxicity conditioning regimen improve the results of stem cell transplantation in metabolic disease?"],"prefix":"10.1038","volume":"37","author":[{"given":"S","family":"Cesaro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,1,30]]},"reference":[{"key":"BF1705275_CR1","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1056\/NEJMoa042604","volume":"352","author":"ML Escolar","year":"2005","unstructured":"Escolar ML, Poe MD, Provenzale JM, Richards KC, Allison J, Wood S et al. Transplantation of umbilical-cord blood in babies with infantile Krabbe's Disease. N Engl J Med 2005; 352: 2069\u20132081.","journal-title":"N Engl J Med"},{"key":"BF1705275_CR2","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1182\/blood.V93.7.2196","volume":"93","author":"O Ringden","year":"1999","unstructured":"Ringden O, Remberger M, Ruutu T, Nikoskelainen J, Volin L, Vindelov L et al. Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia: Nordic Bone Marrow Transplantation Group. Blood 1999; 93: 2196\u20132201.","journal-title":"Blood"},{"key":"BF1705275_CR3","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1182\/blood.V85.11.3005.bloodjournal85113005","volume":"85","author":"SI Bearman","year":"1995","unstructured":"Bearman SI . The syndrome of hepatic veno-occlusive disease after marrow transplantation. Blood 1995; 85: 3005\u20133020.","journal-title":"Blood"},{"key":"BF1705275_CR4","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1182\/blood-2002-11-3615","volume":"103","author":"J Casper","year":"2004","unstructured":"Casper J, Knauf W, Kiefer T, Wolff D, Steiner B, Hammer U et al. Treosulfan and fludarabine: a new toxicity-reduced conditioning regimen for allogeneic hematopoietic stem cell transplantation. Blood 2004; 103: 725\u2013731.","journal-title":"Blood"},{"key":"BF1705275_CR5","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/sj.bmt.1704784","volume":"35","author":"DW Beelen","year":"2005","unstructured":"Beelen DW, Trenschel R, Casper J, Freund M, Hilger RA, Scheulen ME et al. Dose-escalated treosulphan in combination with cyclophoshamide as a new preparative regimen for allogeneic haematopoietic stem cell transplantation in patients with an increased risk for regimen-related complications. Bone Marrow Transplant 2005; 35: 233\u2013241.","journal-title":"Bone Marrow Transplant"},{"issue":"S2","key":"BF1705275_CR6","first-page":"261","volume":"35","author":"J Wachowiak","year":"2005","unstructured":"Wachowiak J, Chybicka A, Kowalczyk J, Boruczkowski D, Wojcik B, Grund G et al. Retrospective study on treosulfan-based preparative regimen for allogeneic HSCT in children with haematological malignancies and high-risk of conventional regimen-related toxicity. Bone Marrow Transplant 2005; 35 (S2): 261.","journal-title":"Bone Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1705275","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705275.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705275.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:45:50Z","timestamp":1648082750000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1705275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,30]]},"references-count":6,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,3,1]]}},"alternative-id":["BF1705275"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1705275","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1,30]]},"assertion":[{"value":"30 January 2006","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}